3rd Circ. Lipitor Ruling Smooths Way In Pay-For-Delay Suits
By Eric Kroh · August 30, 2017, 5:57 PM EDT
The Third Circuit recently revived a suit accusing pharmaceutical companies of delaying generic competition for Lipitor and Effexor XR, a decision that will bolster drug buyers in pay-for-delay cases by beating...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login